Sponsor
Pharma Start LLC
Bulv. Havela Vatslava 8, 03124
About the sponsor
Research activity is centered on antihypertensive therapy, with focus on a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide used in the management of hypertension.
- Blood pressure control
- Combination therapy
- Vascular and renal protection
The sponsor's clinical interest lies in comparative evaluation of cardiovascular medicines intended for routine treatment of elevated blood pressure.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.